Psoriasis | Arcutis | ARQ-151-301
Pharmaceutical Company/Sponsor:
Arcutis
Code:
ARQ-151-301
Title:
A Phase 3, 8-Week, Parallel Group, Double Blind, Vehicle-Controlled Study of the Safety and Efficacy of ARQ-151 Cream 0.3% Administered QD in Subjects With Chronic Plaque Psoriasis
Type:
Interventional
Phase:
3
Condition/Disease:
Psoriasis
Intervention(s)/Treatment(s):
Drug: ARQ-151 0.3% cream
Drug: ARQ-151 vehicle cream
Status:
Recruiting
Link for Additional Information:
